786 related articles for article (PubMed ID: 19371816)
21. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors.
Sarasquete ME; González M; San Miguel JF; García-Sanz R
Oral Dis; 2009 Sep; 15(6):382-7. PubMed ID: 19413677
[TBL] [Abstract][Full Text] [Related]
22. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
Reid IR; Bolland MJ; Grey AB
Bone; 2007 Sep; 41(3):318-20. PubMed ID: 17572168
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates and osteonecrosis of the jaws.
Mariotti A
J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle?
Otto S; Hafner S; Mast G; Tischer T; Volkmer E; Schieker M; Stürzenbaum SR; von Tresckow E; Kolk A; Ehrenfeld M; Pautke C
J Oral Maxillofac Surg; 2010 May; 68(5):1158-61. PubMed ID: 20138420
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
26. [Bisphosphonate-related osteonecrosis of the jaw].
Franken AA; van Blijderveen NJ; Witjes MJ; Netelenbos CJ
Ned Tijdschr Geneeskd; 2011; 155():A3077. PubMed ID: 21486510
[TBL] [Abstract][Full Text] [Related]
27. [Encounter of cancer cells with bone. Present status and problems in occurrence of bisphosphonate-related osteonecrosis of the jaws].
Urade M
Clin Calcium; 2011 Mar; 21(3):420-7. PubMed ID: 21358064
[TBL] [Abstract][Full Text] [Related]
28. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.
Colella G; Campisi G; Fusco V
J Oral Maxillofac Surg; 2009 Dec; 67(12):2698-9. PubMed ID: 19925998
[No Abstract] [Full Text] [Related]
29. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development.
Ruggiero SL
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):13-8. PubMed ID: 19371810
[TBL] [Abstract][Full Text] [Related]
30. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
King AE; Umland EM
Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
[TBL] [Abstract][Full Text] [Related]
31. Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws.
Allegra A; Alonci A; Penna G; Granata A; Nastro Siniscalchi E; Oteri G; Loddo S; Teti D; Cicciù D; De Ponte FS; Musolino C
Acta Haematol; 2010; 124(2):79-85. PubMed ID: 20639624
[TBL] [Abstract][Full Text] [Related]
32. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series.
Lodi G; Sardella A; Salis A; Demarosi F; Tarozzi M; Carrassi A
J Oral Maxillofac Surg; 2010 Jan; 68(1):107-10. PubMed ID: 20006163
[TBL] [Abstract][Full Text] [Related]
33. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
Lazarovici TS; Yahalom R; Taicher S; Schwartz-Arad D; Peleg O; Yarom N
J Oral Maxillofac Surg; 2010 Apr; 68(4):790-6. PubMed ID: 20307764
[TBL] [Abstract][Full Text] [Related]
34. Warning: bisphosphonates and osteochemonecrosis of the jaws.
Flint SR; Sharkey S; Galvin S
J Ir Dent Assoc; 2006; 52(2):79-83. PubMed ID: 16989369
[TBL] [Abstract][Full Text] [Related]
35. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.
Chaudhry AN; Ruggiero SL
Oral Maxillofac Surg Clin North Am; 2007 May; 19(2):199-206, vi. PubMed ID: 18088878
[TBL] [Abstract][Full Text] [Related]
36. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy.
Favia G; Pilolli GP; Maiorano E
Bone; 2009 Sep; 45(3):406-13. PubMed ID: 19450715
[TBL] [Abstract][Full Text] [Related]
37. Surgical management of bisphosphonate-related osteonecrosis of the jaw in oncologic patients: a challenging problem.
Eckardt AM; Lemound J; Lindhorst D; Rana M; Gellrich NC
Anticancer Res; 2011 Jun; 31(6):2313-8. PubMed ID: 21737657
[TBL] [Abstract][Full Text] [Related]
38. The role of bisphosphonates in medical oncology and their association with jaw bone necrosis.
Eid A; Atlas J
Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):231-7. PubMed ID: 24794267
[TBL] [Abstract][Full Text] [Related]
39. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
Gering A; Grange L; Villier C; Woeller A; Mallaret M
Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
[TBL] [Abstract][Full Text] [Related]
40. Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study.
Perrotta I; Cristofaro MG; Amantea M; Russo E; De Fazio S; Zuccalà V; Conforti F; Amorosi A; Donato G; Tripepi S; Giudice M
Ultrastruct Pathol; 2010 Aug; 34(4):207-13. PubMed ID: 20594040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
